Last reviewed · How we verify
Post-Op acetaminophen
Centrally acting analgesic
Centrally acting analgesic Used for Pain relief, Fever reduction.
At a glance
| Generic name | Post-Op acetaminophen |
|---|---|
| Sponsor | Nevakar, Inc. |
| Drug class | Non-opioid analgesic |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 2 |
Mechanism of action
Acetaminophen acts centrally in the brain to relieve pain and reduce fever.
Approved indications
- Pain relief
- Fever reduction
Common side effects
- Hepatotoxicity
- Nausea
- Vomiting
Key clinical trials
- SCHF Post-Op Study Between Opioid and Non-Opioid Pain Management (PHASE4)
- Opioid Use After Laparoscopic Salpingectomy (PHASE4)
- Post-Op Pain Control for Prophylactic Intramedullary Nailing. (PHASE3)
- RCT: Suzetrigine vs Norco for Post-op Pain (PHASE4)
- Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies (PHASE4)
- ERAS Program Implementation for MIPD (NA)
- Comparing Perioperative Outcomes in Pain Control (PHASE4)
- Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Post-Op acetaminophen CI brief — competitive landscape report
- Post-Op acetaminophen updates RSS · CI watch RSS
- Nevakar, Inc. portfolio CI